Guggenheim Capital’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,217
Closed -$90K 2431
2018
Q1
$90K Sell
4,217
-98
-2% -$1.37K ﹤0.01% 2668
2017
Q4
$39K Sell
4,315
-539
-11% -$6.41K ﹤0.01% 2640
2017
Q3
$85K Buy
4,854
+10
+0.2% +$168 ﹤0.01% 2660
2017
Q2
$75K Buy
4,844
+10
+0.2% +$114 ﹤0.01% 2711
2017
Q1
$50K Buy
4,834
+2,216
+85% +$23.7K ﹤0.01% 2734
2016
Q4
$35K Buy
2,618
+12
+0.5% +$153 ﹤0.01% 2816
2016
Q3
$36K Buy
2,606
+5
+0.2% +$82 ﹤0.01% 2787
2016
Q2
$32K Buy
2,601
+157
+6% +$2.02K ﹤0.01% 2789
2016
Q1
$33K Sell
2,444
-530
-18% -$6.76K ﹤0.01% 2806
2015
Q4
$66K Buy
2,974
+102
+4% +$2.21K ﹤0.01% 2875
2015
Q3
$56K Sell
2,872
-162
-5% -$3.68K ﹤0.01% 2844
2015
Q2
$73K Buy
3,034
+1,327
+78% +$31.2K ﹤0.01% 2929
2015
Q1
$33K Buy
1,707
+84
+5% +$999 ﹤0.01% 2964
2014
Q4
$13K Buy
1,623
+298
+22% +$2.91K ﹤0.01% 2984
2014
Q3
$19K Sell
1,325
-3,086
-70% -$47.8K ﹤0.01% 2966
2014
Q2
$80K Sell
4,411
-441
-9% -$6.19K ﹤0.01% 3030
2014
Q1
$65K Buy
4,852
+1,103
+29% +$19.2K ﹤0.01% 3087
2013
Q4
$65K Buy
3,749
+222
+6% +$3.36K ﹤0.01% 3028
2013
Q3
$47K Buy
3,527
+371
+12% +$4.4K ﹤0.01% 2940
2013
Q2
$33K Buy
+3,156
New +$35.1K ﹤0.01% 2943

Other funds holding DRRX

Guggenheim Capital's DRRX Position: Q2 2018 in Review

Guggenheim Capital sold out of DURECT Corp (DRRX) in Q2 2018, closing a stake of 4,217 shares — an estimated $90K sold.

Guggenheim Capital first reported a position in DRRX in Q2 2013 and held it in 20 quarters. The position peaked at $90K in Q1 2018. 102 funds tracked by Wall St. Rank hold DRRX as of Q2 2018.

  • Guggenheim Capital reported no remaining DURECT Corp position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 4,217 DURECT Corp shares in Q2 2018, an estimated $90K.
  • Guggenheim Capital first reported a position in DURECT Corp in Q2 2013 and held it in 20 quarters.
  • Guggenheim Capital's DURECT Corp position peaked at $90K in Q1 2018.
  • 102 funds tracked by Wall St. Rank held DURECT Corp as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.